ALung Technologies

ALung Technologies

A medical device company for patients with respiratory failure. Developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation.

All edits

Edits on 28 Mar, 2021
Golden AI"Found on funding round"
Golden AI edited on 28 Mar, 2021
Edits made to:
Infobox (+3 properties)
Infobox
Investors
Philips
Edits on 6 Oct, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 6 Oct, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
April 11, 2017
Edits on 25 Sep, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 25 Sep, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
60,000,000
Total funding amount (USD)
96,000,000
Golden AI
Golden AI edited on 25 Sep, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
ALung Technologies Series C round, April 2017
Edits on 2 Sep, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 2 Sep, 2020
Edits made to:
Infobox (+1/-1 properties)
Infobox
Total funding amount (USD)
24,000,000
Total funding amount (USD)
60,000,000
Golden AI
Golden AI edited on 2 Sep, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
ALung Technologies Funding Round 2017
Edits on 17 Jul, 2020
Golden AI"Funding autocalculation"
Golden AI edited on 17 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
24,000,000
Edits on 2 Apr, 2020
Arthur Smalley
Arthur Smalley edited on 2 Apr, 2020
Edits made to:
Infobox (-1 properties)
Infobox
Industry
Extracorporeal membrane oxygenation
Edits on 31 Mar, 2020
Arthur Smalley
Arthur Smalley edited on 31 Mar, 2020
Edits made to:
People (+1 rows) (+3 cells) (+78 characters)
People

Name
Role
LinkedIn

Peter M. DeComo

Chairman and CEO

Golden AI
Golden AI edited on 31 Mar, 2020
Edits made to:
Infobox (+1 properties)
Infobox
CEO
Peter M. DeComo
Edits on 30 Mar, 2020
Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 30 Mar, 2020
Edits made to:
Article (+19/-19 characters)
Article

ALung Technologies is an advanced medical device company for treating respiratory failurerespiratory failure. The company is developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation. The Hemolung RAS provides Respiratory Dialysis, a less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung RAS allows the patient’s lungs to rest and heal. Applications of the device include preventing intubation in acute exacerbation of chronic obstructive pulmonary disease (COPD) and enabling ultra-protective ventilation in acute respiratory distress syndrome (ARDS).

Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 30 Mar, 2020
Edits made to:
Article (+14/-14 characters)
Article

ALung Technologies is an advanced medical devicemedical device company for treating respiratory failure. The company is developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation. The Hemolung RAS provides Respiratory Dialysis, a less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung RAS allows the patient’s lungs to rest and heal. Applications of the device include preventing intubation in acute exacerbation of chronic obstructive pulmonary disease (COPD) and enabling ultra-protective ventilation in acute respiratory distress syndrome (ARDS).

Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 30 Mar, 2020
Edits made to:
Article (+12/-12 characters)
Article

The company was founded in 1997 and is based in Pittsburgh, PennsylvaniaPennsylvania.

Arthur Smalley
Arthur Smalley approved a suggestion from Golden's AI on 30 Mar, 2020
Edits made to:
Article (+13/-13 characters)
Article

ALung’s Hemolung RAS was originally developed at the University of Pittsburgh. The device is limited by United StatesUnited States law to investigational use. ALung is conducting a pivotal investigational device exemption trial of the Hemolung Respiratory Assist System for the treatment of adults with severe acute exacerbations of chronic obstructive pulmonary disease (COPD). The VENT-AVOID Trial is the first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations.

Arthur Smalley
Arthur Smalley edited on 30 Mar, 2020
Edits made to:
Description (+189/-64 characters)
Article (+593/-605 characters)
Topic thumbnail

ALung Technologies

A medical device developer for patients with respiratory failure

A medical device company for patients with respiratory failure. Developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation.

Article

ALung Technologies is an advanced medical device company for treating respiratory failure. The companiescompany is developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation. The Hemolung RAS provides Respiratory Dialysis, a less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung RAS allows the patient’s lungs to rest and heal. Applications of the device include preventing intubation in acute exacerbation of chronic obstructive pulmonary disease (COPD) and enabling ultra-protective ventilation in acute respiratory distress syndrome (ARDS).

ALung’s Hemolung RAS was originally developed at the University of Pittsburgh. The device is limited by United States law to investigational use. ALung is currently conducting a pivotal investigational device exemption trial of the Hemolung Respiratory Assist System for the treatment of adults with severe acute exacerbations of chronic obstructive pulmonary disease (COPD). The VENT-AVOID Trial is the first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations.

The company was founded in 1997 and is based in Pittsburgh, Pennsylvania.

...

ALung’s Hemolung RAS was originally developed at the University of Pittsburgh. The device is limited by United States law to investigational use. ALung is conducting a pivotal investigational device exemption trial of the Hemolung Respiratory Assist System for the treatment of adults with severe acute exacerbations of chronic obstructive pulmonary disease (COPD). The VENT-AVOID Trial is the first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations.

...

The company was founded in 1997 and is based in Pittsburgh, Pennsylvania.

Arthur Smalley
Arthur Smalley edited on 30 Mar, 2020
Edits made to:
Article (+1280 characters)
Article

ALung Technologies is an advanced medical device company for treating respiratory failure. The companies is developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation. The Hemolung RAS provides Respiratory Dialysis, a less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung RAS allows the patient’s lungs to rest and heal. Applications of the device include preventing intubation in acute exacerbation of chronic obstructive pulmonary disease (COPD) and enabling ultra-protective ventilation in acute respiratory distress syndrome (ARDS).

ALung’s Hemolung RAS was originally developed at the University of Pittsburgh. The device is limited by United States law to investigational use. ALung is currently conducting a pivotal investigational device exemption trial of the Hemolung Respiratory Assist System for the treatment of adults with severe acute exacerbations of chronic obstructive pulmonary disease (COPD). The VENT-AVOID Trial is the first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations.

The company was founded in 1997 and is based in Pittsburgh, Pennsylvania.

Edits on 27 Mar, 2020
Arthur Smalley
Arthur Smalley edited on 27 Mar, 2020
Edits made to:
Infobox (+2 properties)
Infobox
Founded date
1997
Full address
2500 Jane St Ste 1, Pittsburgh, PA 15203, US
Edits on 25 Mar, 2020
Arthur Smalley
Arthur Smalley edited on 25 Mar, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Extracorporeal membrane oxygenation
Edits on 24 Mar, 2020
Arthur Smalley
Arthur Smalley edited on 24 Mar, 2020
Edits made to:
Categories (+1 topics)
Categories
Arthur Smalley
Arthur Smalley edited on 24 Mar, 2020
Edits made to:
Infobox (+2 properties)
Infobox
Industry
Respiratory care
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.